(Press-News.org) Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly diagnosed glioblastoma (GBM). The recent analysis of the proton cohort revealed improved survival for patients receiving proton therapy at 75 Gy. Because this data met the pre-defined survival improvement threshold, they could be used to design and conduct a definitive phase III randomized trial. These results were recently reported at the American Society for Radiation Oncology Annual Meeting in San Francisco, California.
“We had developed this trial to test the potential survival advantage using proton therapy combined with temozolomide for GBM with the dual hypothesis of the benefit of dose-escalation and the sparing effect on lymphocytes in circulation, critical in maintaining an anti-tumor immune response, and are excited to report that the predefined signal to support the development of a definitive Phase III trial of proton dose-escalation for GBM has been achieved.”, shared Minesh P. Mehta, MD, with Baptist Health Miami Cancer Institute and Florida International University Herbert Wertheim College of Medicine and the lead author of the NRG-BN001 abstract.
Data from prior single-arm, non-randomized studies utilizing temozolomide established simultaneous integrated boost (SIB) radiation therapy dose intensification to 75 Gy as safe and effective in patients with GBM. NRG-BN001 was designed as a phase II study testing the hypothesis that this dose intensified regimen could be potentially as or more effective in treating patients with GBM. Additionally, lymphopenia is commonly associated with the low dose region commonly encountered with photon radiotherapy and has been demonstrated to have dose-volume dependency, and a survival decrement with lymphopenia in GBM has been established. Proton therapy has been demonstrated to decrease the occurrence of acute severe lymphopenia, suggesting a potential biologic mechanism of benefit for GBM patients. NRG-BN001 addressed both hypotheses comparing 75 Gy intensity modulated radiation therapy (IMRT) and 75 Gy proton therapy to standard of care 60 Gy radiation therapy.
The proton therapy cohort of NRG-BN001 included 193 evaluable patients. The proton therapy arm demonstrated improved OS (HR= 0.81, 70% CI 0.67-0.98, p =0.11 (prespecified type I error of 0.15)) and the improvement in survival remained significant when correcting for MGMT methylation status and recursive partitioning analysis (RPA) class. The absolute survival improvement in favor of the proton therapy arm at 2 and 3 years was 6.8% (43.1 vs 49.9%) and 4.6% (25.4 vs 30%). As expected, OS was superior for both MGMT methylated as well as for lower recursive partitioning analysis (RPA) class patients, and without significant interaction between treatment arm and either MGMT status or RPA. There was no statistically significant difference in high grade toxicities between treatment arms. Specifically, ≥G3 lymphopenia and ≥G4 neurologic toxicity rates for 60 Gy vs. 75 Gy proton therapy were 23.4 vs 17.1 (absolute difference of 6.3%), and 5 vs 1.8% (absolute difference of 3.2%).
Further research needs to be conducted in a phase III trial setting to determine the full potential benefit for proton therapy in this patient population.
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number U10CA180868 (NRG Oncology Operations), UG1CA189867 (NCORP), U10CA180822 (NRG Oncology SDMC), U24CA196067 (NRG Specimen Bank), U24CA180803 (IROC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Special Podcast Episode
Follow The NRG Oncology Podcast on Spotify, Apple Podcasts, and YouTube for a special episode interviewing Dr. Minesh Mehta on the findings of the 2025 ASTRO Late-Breaking Session Presentation for NRG-BN001. Podcast information and playable episodes are available on the NRG website as well.
Citation
Mehta MP, Pugh SL, Mahajan A, Shih HA, Tsien CI, Chenevert TL, Gilbert MR, Omuro AA, Aldape KD, Teo BK, Cao Y, Srinivasan A, Khan OH, Huang J, Brown PD, Kotecha RR, Vempati P, Yeboa DN, Won M, Gondi V. Signal-Seeking P2R Trial of Proton or IMRT Dose Intensification in GBM: NRG BN001. Paper presented during the Plenary Session at the annual meeting of the American Society for Radiation Oncology. San Francisco, CA. (2025, September-October).
About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs. The research network seeks to carry out clinical trials with emphasis on sex-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology’s extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI’s National Clinical Trials Network. www.nrgoncology.org
END
NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III
2025-09-30
ELSE PRESS RELEASES FROM THIS DATE:
In a landmark move, ECMWF is poised to announce a new phase in its data sharing strategy
2025-09-30
As part of its strategy and ongoing commitment to open science, ECMWF (The European Centre for Medium-Range Weather Forecasts) has been opening its extensive data catalogue and making its science more widely open and accessible.
The organisation holds one of the world’s largest meteorological archives, exceeding 1.3 exabytes of data. Starting with historical data and charts, and ECMWF is now moving to make real-time forecast data openly available. By making its data openly available, ECMWF is supporting the UN’s Early Warnings for All initiative and enabling societies ...
Seal’s sensitive whiskers hold key to foiling fish escapes
2025-09-30
Life beneath the waves can be a game of cat and mouse. Seals pursue swimming fish by following the tell-tale wakes and spinning vortices they leave behind, sensing the faint swirls with their sensitive whiskers. But fish might have a trick up their sleeves. Yvonne Krüger from University of Rostock, Germany, explains that escaping fish produce three jets of different sizes they dart away, squirting in individual directions almost simultaneously – at least two of which form into vortex rings, like smoke rings – which could confuse a seal. But might seals be able to see through the ...
Neurological outcomes after patients suffer cardiac arrest at home are similar between low- and high-income areas in Vienna
2025-09-30
Vienna, Austria: People who have a cardiac arrest in their own homes have similar neurological outcomes regardless of socioeconomic background, according to research presented at the European Emergency Medicine Congress today (Wednesday) [1].
However, the study of 676 patients who received treatment in the Department of Emergency Medicine at the Medical University of Vienna suggested that those who lived in lower-income areas may be less likely to receive cardiopulmonary resuscitation (CPR) from bystanders compared to people suffering a cardiac arrest (when the heart stops pumping blood around the body) in higher-income areas – a finding ...
Precision without incision: the new era of functional radiosurgery
2025-09-30
MIAMI, FLORIDA (Sept. 30, 2025) -- Research findings from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, are being presented this week at ASTRO 2025 – the American Society for Radiation Oncology’s annual meeting in San Francisco.
Markus Bredel, M.D., Ph.D., professor and chair of the Miller School’s Department of Radiation Oncology, presented at the Presidential Symposium, focusing on “Precision Without Incision: The New Era of Functional Radiosurgery.” His session, “Classical Movement Disorders and Connectomics: Image-Guided ...
University of Miami scientists launch accessible global climate modeling framework
2025-09-30
University of Miami scientists launch accessible global climate modeling framework
Designed for education, adaptable for research—the new Python-based framework makes climate dynamics more approachable for students and researchers
Miami, FL — A team of researchers at the University of Miami has developed a global atmospheric modeling framework that blends powerful research capabilities with accessibility for students and scientists alike. Written entirely in Python, a high-level, general-purpose programming language, and designed to run on an interactive Jupyter Notebook, the ...
Parallel atom-photon entanglement paves way for future quantum networking
2025-09-30
A new platform developed by Illinois Grainger engineers demonstrates the utility of a ytterbium-171 atom array in quantum networking. Their work represents a key step toward long distance quantum communication.
A new platform developed by Illinois Grainger engineers demonstrates the utility of a ytterbium-171 atom array in quantum networking. Their work represents a key step toward long distance quantum communication.
Researchers from The Grainger College of Engineering at the University of Illinois Urbana-Champaign have introduced a scalable platform for quantum networking with a ytterbium-171 ...
Single-step battery cathode recycling
2025-09-30
A new battery recycling method developed by Illinois Grainger engineers removes scarce, expensive metals from old battery cathodes and coats them onto new cathodes in a single step. The result is significantly more affordable, less environmentally impactful and less risky to health than any recycling method currently in use.
Battery cathodes – the positive part of the battery that helps to store electrical energy – often require rare, expensive metals such as cobalt. It is therefore crucial to develop effective means for recycling cathodes that reclaim the metals essential to their operation.
Researchers in The Grainger College of Engineering at the University of Illinois ...
Farm conservation is an economical path to save Colorado River water
2025-09-30
The most cost-effective way to conserve the dwindling waters of the Colorado River may not come from building new reservoirs, canals, or wells, but from changing how water is used on farms that consume most of it.
That’s the conclusion of a comprehensive study by UC Riverside’s School of Public Policy, conducted with the Utah Rivers Council.
Led by UCR graduate student Paloma Avila, the study examined 462 federally funded Colorado River conservation and supply projects, totaling about $1 billion (in 2023 constant dollars) between 2004 and 2024, using available spending data from the U.S. Bureau of Reclamation.
It ...
Feeling in control helps beat daily stress, researchers find
2025-09-30
UNIVERSITY PARK, Pa. — A looming deadline at work, a clogged toilet, an argument with a loved one — these daily hassles can make any day feel more stressful. When these demands pile up, it can feel overwhelming, like there’s no end in sight. Yet, the perception of control could make resolving these everyday inconveniences easier, according to a new study from a team including researchers from Penn State.
The research team found that on days when people felt they had more control over stressors ...
The Municipal Finance Journal joins the Chicago Journals program
2025-09-30
We are honored to announce that the Municipal Finance Journal (MFJ) has joined the Chicago Journals publishing program. The journal is published in partnership with the Center for Municipal Finance at the University of Chicago Harris School of Public Policy.
Launched in 1980, MFJ is a forum for research on the issues facing practitioners in state and local finance and tax-exempt financing. Articles address the complicated interplay of legal, market, economic, and political perspectives affecting public finance, ...